Vanguard Group’s Windtree Therapeutics WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-46
Closed -$14.7K 4445
2024
Q1
$14.7K Hold
46
﹤0.01% 4410
2023
Q4
$29.9K Hold
46
﹤0.01% 4416
2023
Q3
$39.5K Buy
+46
New +$51K ﹤0.01% 4439
2023
Q1
Sell
-4
Closed -$28.6K 4579
2022
Q4
$28.6K Sell
4
-6
-60% -$53.3K ﹤0.01% 4478
2022
Q3
$137K Sell
10
-3
-23% -$53.6K ﹤0.01% 4464
2022
Q2
$243K Buy
13
+1
+8% +$29.5K ﹤0.01% 4443
2022
Q1
$629K Sell
12
-3
-20% -$157K ﹤0.01% 4338
2021
Q4
$1.08M Hold
15
﹤0.01% 4250
2021
Q3
$1.38M Buy
15
+1
+7% +$85.1K ﹤0.01% 4168
2021
Q2
$1.43M Buy
14
+2
+17% +$195K ﹤0.01% 4067
2021
Q1
$1.32M Buy
12
+6
+100% +$1.3M ﹤0.01% 3950
2020
Q4
$1.42M Hold
6
﹤0.01% 3743
2020
Q3
$1.51M Buy
+6
New +$2.02M ﹤0.01% 3565

Other funds holding WINT